Guy Fagherazzi, PhD; Douae El Fatouhi, MSc; Agnès Fournier, PhD; et al.
has active quiz
has audio
JAMA Neurol. 2019;76(3):257-263. doi:10.1001/jamaneurol.2018.3960
This longitudinal analysis of a French national cohort evaluates the association of migraine and type 2 diabetes in women, including changes in the prevalence of active migraine episodes before and after type 2 diabetes diagnosis.
-
Audio Interview:
Associations Between Migraine and Type 2 Diabetes in Women—Findings From the E3N Cohort Study
John C. Morris, MD; Suzanne E. Schindler, MD, PhD; Lena M. McCue, PhD; et al.
JAMA Neurol. 2019;76(3):264-273. doi:10.1001/jamaneurol.2018.4249
This cohort study examines whether there are disparities between African American and white individuals in molecular biomarkers for Alzheimer disease.
Yvonne Naegelin, MD; Peter Naegelin; Stefanie von Felten, PhD; et al.
JAMA Neurol. 2019;76(3):274-281. doi:10.1001/jamaneurol.2018.4239
This cohort study uses propensity score–matching analyses to examine disability progression in matched pairs of patients with secondary progressive multiple sclerosis who were treated with rituximab vs those who were never treated with rituximab.
Annemijn M. Algra, MD; Antti Lindgren, MD, PhD; Mervyn D. I. Vergouwen, MD, PhD; et al.
JAMA Neurol. 2019;76(3):282-293. doi:10.1001/jamaneurol.2018.4165
This systematic review and meta-analysis assesses the rates of procedural complications and fatalities within the 30 days after endovascular or neurosurgical treatment for unruptured intracranial aneurysms.
Kimberley J. Smith, PhD; Mark D. Peterson, PhD; Neil E. O’Connell, PhD; et al.
open access
JAMA Neurol. 2019;76(3):294-300. doi:10.1001/jamaneurol.2018.4147
This cohort study assesses depression and anxiety in adults with cerebral palsy compared with age-, sex-, and practice-matched adults with cerebral palsy.
Divyanshu Dubey, MD; Sean J. Pittock, MD; Karl N. Krecke, MD; et al.
has active quiz
JAMA Neurol. 2019;76(3):301-309. doi:10.1001/jamaneurol.2018.4053
This study evaluates the clinical, radiologic,al and prognostic features of of myelin oligodendrocyte glycoprotein autoantibody myelitis and compares with myelitis with aquaporin-4–IgG and multiple sclerosis.
Ruben Smith, MD, PhD; Moa Wibom, MD; Daria Pawlik, MD; et al.
open access
JAMA Neurol. 2019;76(3):310-317. doi:10.1001/jamaneurol.2018.3692
This case study investigates the association of regional in vivo retention of the tau positron emission tomography ligand [18F]flortaucipir with the density of tau neuropathology in the corresponding brain regions in a patient with early-onset Alzheimer disease caused by a PSEN1 mutation.
Bob Olsson, MD, PhD; Erik Portelius, PhD; Nicholas C. Cullen, BS; et al.
JAMA Neurol. 2019;76(3):318-325. doi:10.1001/jamaneurol.2018.3746
This case-control study investigates cerebrospinal fluid levels of neurofilament light protein in participants with various forms of dementia, motor neuron disease, and movement disorders and controls, as determined by clinical and autopsy-definite criteria.
Pinar Kahraman-Koytak, MD; Beau B. Bruce, MD, PhD; Jason H. Peragallo, MD; et al.
JAMA Neurol. 2019;76(3):326-332. doi:10.1001/jamaneurol.2018.3989
This medical record review identifies factors and diagnostic errors that contribute to the initial misdiagnosis of optic nerve sheath meningiomas.
Marc Paul O’Sullivan, BSc; Ann Marie Looney, PhD; Gerard M. Moloney, PhD; et al.
JAMA Neurol. 2019;76(3):333-341. doi:10.1001/jamaneurol.2018.4182
This validation study assesses the ability of a panel of umbilical cord microRNA to evaluate the development and severity of encephalopathy in infants following perinatal asphyxia.
Lynne Rumping, MD; Benjamin Büttner; Oliver Maier, MD; et al.
JAMA Neurol. 2019;76(3):342-350. doi:10.1001/jamaneurol.2018.2941
This study uses exome sequencing and genetic evaluation to explain the shared condition of 4 children from 2 unrelated families who were affected by refractory epileptic seizures, respiratory failure, brain abnormalities, and death in the neonatal period.